[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Takeuchi et al., 2012 - Google Patents

Salivary levels of antibacterial peptide (LL‐37/hCAP‐18) and cotinine in patients with chronic periodontitis

Takeuchi et al., 2012

View PDF
Document ID
9391589914784256485
Author
Takeuchi Y
Nagasawa T
Katagiri S
Kitagawara S
Kobayashi H
Koyanagi T
Izumi Y
Publication year
Publication venue
Journal of periodontology

External Links

Snippet

Background: The purpose of this study is to examine the relationship between salivary LL‐ 37 levels and clinical severity in patients with chronic periodontitis (CP). The presence/absence of four periodontopathic bacteria and salivary cotinine levels were also …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/403—Cells and electrode assemblies
    • G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes

Similar Documents

Publication Publication Date Title
Takeuchi et al. Salivary levels of antibacterial peptide (LL‐37/hCAP‐18) and cotinine in patients with chronic periodontitis
Puklo et al. Analysis of neutrophil‐derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL‐37 in the innate immune response against periodontogenic bacteria
Guentsch et al. Comparison of gingival crevicular fluid sampling methods in patients with severe chronic periodontitis
Mauri‐Obradors et al. Benefits of non‐surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: A randomized controlled trial
Ertugrul et al. Comparison of CCL28, interleukin‐8, interleukin‐1β and tumor necrosis factor‐alpha in subjects with gingivitis, chronic periodontitis and generalized aggressive periodontitis
Gursoy et al. Salivary interleukin‐1β concentration and the presence of multiple pathogens in periodontitis
Teles et al. Relationships between subgingival microbiota and GCF biomarkers in generalized aggressive periodontitis
Türkoğlu et al. Gingival crevicular fluid levels of cathelicidin LL‐37 and interleukin‐18 in patients with chronic periodontitis
Tao et al. Salivary antimicrobial peptide expression and dental caries experience in children
Apatzidou et al. Impact of smoking on the clinical, microbiological and immunological parameters of adult patients with periodontitis
Haririan et al. Salivary and serum chromogranin A and α‐amylase in periodontal health and disease
Kaner et al. Gingival crevicular fluid levels of calprotectin and myeloperoxidase during therapy for generalized aggressive periodontitis
Eick et al. Lack of cathelicidin processing in Papillon-Lefevre syndrome patients reveals essential role of LL-37 in periodontal homeostasis
Nishida et al. Association between passive smoking and salivary markers related to periodontitis
Ye et al. Mutations in the ELANE gene are associated with development of periodontitis in patients with severe congenital neutropenia
Pereira et al. Influence of periodontal status and periodontopathogens on levels of oral human β‐defensin‐2 in saliva
Laugisch et al. Periodontal pathogens affect the level of protease inhibitors in gingival crevicular fluid
Al‐Ghamdi et al. Serum antibody levels in smoker and non‐smoker Saudi subjects with chronic periodontitis
Yang et al. The influences of periodontal status and periodontal pathogen quantity on salivary 8‐hydroxydeoxyguanosine and interleukin‐17 levels
Ertugrul et al. Gingival crevicular fluid levels of human beta‐defensin‐2 and cathelicidin in smoker and non‐smoker patients: a cross‐sectional study
Wang et al. Relationship between expression of human gingival beta‐defensins and levels of periodontopathogens in subgingival plaque
Ito et al. Clinical evaluation of salivary periodontal pathogen levels by real‐time polymerase chain reaction in patients before dental implant treatment
Chigasaki et al. Porphyromonas gingivalis, the most influential pathogen in red‐complex bacteria: A cross‐sectional study on the relationship between bacterial count and clinical periodontal status in Japan
Costa et al. Gingival crevicular fluid levels of human beta‐defensin 1 in individuals with and without chronic periodontitis
Türkoğlu et al. Antimicrobial peptide hCAP‐18/LL‐37 protein and mRNA expressions in different periodontal diseases